These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 8381804

  • 1. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity.
    Imperato-McGinley J, Gautier T, Cai LQ, Yee B, Epstein J, Pochi P.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):524-8. PubMed ID: 8381804
    [Abstract] [Full Text] [Related]

  • 2. C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
    Imperato-McGinley J, Shackleton C, Orlic S, Stoner E.
    J Clin Endocrinol Metab; 1990 Mar; 70(3):777-82. PubMed ID: 1689740
    [Abstract] [Full Text] [Related]

  • 3. 5 alpha-metabolism in finasteride-treated subjects and male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. A review.
    Imperato-McGinley J.
    Eur Urol; 1991 Mar; 20 Suppl 1():78-81. PubMed ID: 1722167
    [Abstract] [Full Text] [Related]

  • 4. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
    Schwartz JI, Tanaka WK, Wang DZ, Ebel DL, Geissler LA, Dallob A, Hafkin B, Gertz BJ.
    J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
    Imperato-McGinley J, Sanchez RS, Spencer JR, Yee B, Vaughan ED.
    Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
    [Abstract] [Full Text] [Related]

  • 6. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G, Rittmaster RS, Klocker H.
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [Abstract] [Full Text] [Related]

  • 7. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK, Ross M, Tate R, Chisholm GD.
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [Abstract] [Full Text] [Related]

  • 8. The effect of a 5 alpha-reductase inhibitor on androgen physiology in the immature male rat.
    George FW, Johnson L, Wilson JD.
    Endocrinology; 1989 Nov; 125(5):2434-8. PubMed ID: 2551651
    [Abstract] [Full Text] [Related]

  • 9. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
    Geller J.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
    [Abstract] [Full Text] [Related]

  • 10. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G, Rittmaster RS, Klocker H.
    World J Urol; 2002 Apr; 19(6):413-25. PubMed ID: 12022710
    [Abstract] [Full Text] [Related]

  • 11. [Dihydrotestosterone and the role of 5 alpha-reductase inhibitors in benign prostatic hyperplasia].
    Bartsch G, Rittmaster RS, Klocker H.
    Urologe A; 2002 Sep; 41(5):412-24. PubMed ID: 12426858
    [Abstract] [Full Text] [Related]

  • 12. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW.
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [Abstract] [Full Text] [Related]

  • 13. Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition.
    Rhodes L, Primka RL, Berman C, Vergult G, Gabriel M, Pierre-Malice M, Gibelin B.
    Prostate; 1993 Mar; 22(1):43-51. PubMed ID: 8381228
    [Abstract] [Full Text] [Related]

  • 14. Dihydrotestosterone regulation of semen in male pseudohermaphrodites with 5 alpha-reductase-2 deficiency.
    Cai LQ, Fratianni CM, Gautier T, Imperato-McGinley J.
    J Clin Endocrinol Metab; 1994 Aug; 79(2):409-14. PubMed ID: 8045956
    [Abstract] [Full Text] [Related]

  • 15. The clinical development of a 5 alpha-reductase inhibitor, finasteride.
    Stoner E.
    J Steroid Biochem Mol Biol; 1990 Nov 20; 37(3):375-8. PubMed ID: 1701660
    [Abstract] [Full Text] [Related]

  • 16. Castration-like effects on the human prostate of a 5 alpha-reductase inhibitor, finasteride.
    Geller J, Sionit L.
    J Cell Biochem Suppl; 1992 Nov 20; 16H():109-12. PubMed ID: 1283893
    [Abstract] [Full Text] [Related]

  • 17. Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.
    Diani AR, Mulholland MJ, Shull KL, Kubicek MF, Johnson GA, Schostarez HJ, Brunden MN, Buhl AE.
    J Clin Endocrinol Metab; 1992 Feb 20; 74(2):345-50. PubMed ID: 1309834
    [Abstract] [Full Text] [Related]

  • 18. Effect of MK-906, a specific 5 alpha-reductase inhibitor, on serum androgens and androgen conjugates in normal men.
    Rittmaster RS, Stoner E, Thompson DL, Nance D, Lasseter KC.
    J Androl; 1989 Feb 20; 10(4):259-62. PubMed ID: 2550402
    [Abstract] [Full Text] [Related]

  • 19. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    Stanczyk FZ, Azen CG, Pike MC.
    J Steroid Biochem Mol Biol; 2013 Nov 20; 138():10-6. PubMed ID: 23474436
    [Abstract] [Full Text] [Related]

  • 20. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
    Hirsch KS, Jones CD, Audia JE, Andersson S, McQuaid L, Stamm NB, Neubauer BL, Pennington P, Toomey RE, Russell DW.
    Proc Natl Acad Sci U S A; 1993 Jun 01; 90(11):5277-81. PubMed ID: 8389478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.